Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
OPCH Stock Forecast 2026-2027
$21.70
Current Price
$3.41B
Market Cap
Buy 10
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to OPCH Price Targets
+79.7%
To High Target of $39.00
+33.6%
To Median Target of $29.00
+1.4%
To Low Target of $22.00
OPCH Price Momentum
+0.6%
1 Week Change
+4.5%
1 Month Change
-29.3%
1 Year Change
-31.9%
Year-to-Date Change
-41.0%
From 52W High of $36.80
+20.5%
From 52W Low of $18.01
📊 TOP ANALYST CALLS
Did OPCH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Option Care is one of their latest high-conviction picks.
Latest OPCH Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, OPCH has a bullish consensus with a median price target of $29.00 (ranging from $22.00 to $39.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $21.70, the median forecast implies a 33.6% upside. This outlook is supported by 10 Buy, 3 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Scott Fidel at Goldman Sachs, suggesting a 1.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
OPCH Analyst Ratings
10
Buy
3
Hold
0
Sell
OPCH Price Target Range
Low
$22.00
Average
$29.00
High
$39.00
Current: $21.70
Latest OPCH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for OPCH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 8, 2026 | Goldman Sachs | Scott Fidel | Neutral | Initiates | $22.00 |
| May 6, 2026 | Morgan Stanley | Overweight | Maintains | $N/A | |
| May 4, 2026 | JP Morgan | Overweight | Maintains | $N/A | |
| May 1, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| May 1, 2026 | UBS | Buy | Maintains | $N/A | |
| May 1, 2026 | TD Cowen | Hold | Maintains | $N/A | |
| Jan 16, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| Jan 13, 2026 | Morgan Stanley | Overweight | Maintains | $N/A | |
| Jan 13, 2026 | Citizens | Market Outperform | Reiterates | $N/A | |
| Dec 11, 2025 | Stephens & Co. | Overweight | Initiates | $N/A | |
| Dec 9, 2025 | B of A Securities | Buy | Maintains | $N/A | |
| Dec 9, 2025 | Deutsche Bank | Buy | Maintains | $N/A | |
| Nov 3, 2025 | TD Cowen | Hold | Maintains | $N/A | |
| Oct 31, 2025 | Citizens | Market Outperform | Maintains | $N/A | |
| Oct 31, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Oct 17, 2025 | Morgan Stanley | Overweight | Initiates | $N/A | |
| Oct 2, 2025 | TD Cowen | Hold | Initiates | $N/A | |
| Sep 23, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Jul 31, 2025 | JMP Securities | Market Outperform | Maintains | $N/A | |
| Jul 10, 2025 | Barrington Research | Outperform | Maintains | $N/A |
Option Care Health Inc. (OPCH) Competitors
The following stocks are similar to Option Care based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
OPCH
Option Care Health
mkt cap
3.39B
Option Care Health Inc. (OPCH) Financial Data
Option Care Health Inc. has a market capitalization of $3.41B with a P/E ratio of 17.0x. The company generates $5.67B in trailing twelve-month revenue with a 3.6% profit margin.
Revenue growth is +1.3% quarter-over-quarter, while maintaining an operating margin of +5.4% and return on equity of +15.3%.
Valuation Metrics
Market Cap
$3.41B
Enterprise Value
$4.48B
P/E Ratio
17.0x
PEG Ratio
4.8x
Price/Sales
0.6x
Growth & Margins
Revenue Growth (YoY)
+1.3%
Gross Margin
+19.4%
Operating Margin
+5.4%
Net Margin
+3.6%
EPS Growth
-3.0%
Financial Health
Cash/Price Ratio
+5.3%
Current Ratio
1.6x
Debt/Equity
94.0x
ROE
+15.3%
ROA
+6.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Option Care Health Inc. (OPCH) Business Model
About Option Care Health Inc.
What They Do
Provides infusion therapy and healthcare services.
Business Model
The company operates a network of facilities and home-based services to deliver infusion therapy and related care, generating revenue through personalized treatment plans for patients with critical illnesses. It focuses on bridging the gap between hospitals and home care, thus enhancing patient outcomes and managing chronic health conditions.
Additional Information
Option Care Health Inc. addresses the increasing demand for specialty medications and integrated healthcare solutions, positioning itself as a vital player in the health services sector. Its emphasis on clinical expertise and patient-centered care helps it meet the needs of patients with immune disorders, cancer, and other chronic conditions.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
6,528
CEO
Mr. John Charles Rademacher
Country
United States
IPO Year
1996
Website
optioncarehealth.comOption Care Health Inc. (OPCH) Latest News & Analysis
Latest News
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
4 days ago
Quick Summary
Option Care Health Inc. (NASDAQ: OPCH) will release its Q2 2026 results on July 29, 2026, before market open, followed by a conference call at 8:30 a.m. E.T.
Why It Matters
Option Care Health's upcoming earnings release and conference call could significantly impact its stock price, providing insights into financial performance and future growth potential.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Option Care Health, Inc. (NASDAQ: OPCH) appointed Robert Okunski as Vice President of Investor Relations, effective May 26, 2026.
Why It Matters
The appointment of Robert Okunski as VP of Investor Relations signals a focus on enhancing communication with investors, potentially improving transparency and shareholder confidence in Option Care Health.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Option Care Health has been ranked No. 15 on the World's Most Impactful Companies 2026 list, highlighting its positive societal, environmental, and economic contributions.
Why It Matters
Option Care Health's ranking as a top impactful company enhances its reputation, potentially attracting investors focused on ESG criteria and boosting stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
OPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.
1 month ago
Quick Summary
Kirby McInerney LLP is investigating Option Care Health, Inc. (NASDAQ: OPCH) for potential violations of federal securities laws and unlawful business practices by the company or its senior management.
Why It Matters
The investigation into Option Care Health for potential securities law violations can lead to legal risks, impacting stock performance and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Option Care Health (NASDAQ: OPCH) shares fell 25%-30% on April 30, 2026, after Q1 2026 revenue missed estimates and the company lowered its FY 2026 guidance to $5.675-$5.775 billion.
Why It Matters
Option Care Health's significant stock drop reflects investor reaction to poor Q1 earnings and lowered full-year guidance, indicating weaker future performance and potential volatility.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
The Law Offices of Frank R. Cruz are investigating Option Care Health, Inc. (NASDAQ: OPCH) for potential violations of federal securities laws impacting investors.
Why It Matters
The investigation into Option Care Health may indicate potential legal issues and financial risks, impacting stock performance and investor confidence in the company.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About OPCH Stock
What is Option Care Health Inc.'s (OPCH) stock forecast for 2027?
Based on our analysis of 3 Wall Street analysts, Option Care Health Inc. (OPCH) has a median price target of $29.00. The highest price target is $39.00 and the lowest is $22.00.
Is OPCH stock a good investment in 2027?
According to current analyst ratings, OPCH has 10 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $21.70. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for OPCH stock?
Wall Street analysts predict OPCH stock could reach $29.00 in the next 12 months. This represents a 33.6% increase from the current price of $21.70. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Option Care Health Inc.'s business model?
The company operates a network of facilities and home-based services to deliver infusion therapy and related care, generating revenue through personalized treatment plans for patients with critical illnesses. It focuses on bridging the gap between hospitals and home care, thus enhancing patient outcomes and managing chronic health conditions.
What is the highest forecasted price for OPCH Option Care Health Inc.?
The highest price target for OPCH is $39.00 from at , which represents a 79.7% increase from the current price of $21.70.
What is the lowest forecasted price for OPCH Option Care Health Inc.?
The lowest price target for OPCH is $22.00 from Scott Fidel at Goldman Sachs, which represents a 1.4% increase from the current price of $21.70.
What is the overall OPCH consensus from analysts for Option Care Health Inc.?
The overall analyst consensus for OPCH is bullish. Out of 3 Wall Street analysts, 10 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $29.00.
How accurate are OPCH stock price projections?
Stock price projections, including those for Option Care Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 14, 2026 3:26 AM UTC